Since redefining the cosmetic peptide landscape in the 1990s, Matrixyl has become a benchmark in advanced skin care. Now, Croda Beauty Actives has unveiled Matrixyl Neolide, which is powered by cutting-edge encapsulation for precise peptide delivery and sustained activity over time.

The new patented technology safeguards Matrixyl in formulations, controls its release within the skin (+15 days of peptide release), and ensures consistent performance consumers can rely on.

Encapsulation enhances stability and potency, allowing brands to design formulas with reduced “formulation noise” and more predictable efficacy, according to Croda.

Early clinical data reveal visible firming in just two weeks (+25 %, p<0.01 vs T0), offering rapid, visible results.

Matrixyl Neolide also partners well with modern routines—from professional skin protocols to recovery care after gentle aesthetic treatments—showcasing remarkable synergy with microneedling applications, according to the company.

At 99.79% natural-origin content (per ISO16128), Matrixyl Neolide has a lower carbon footprint (-43%) compared to Matrixyl, is TFAs-free, RSPO and vegan suitable.

In-Cosmetics Stand No. 3F50 | http://www.crodabeauty.com